BA
PGNX
BKS Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $550K | Buy |
118,587
+5,102
| +4% | +$23.7K | 0.22% | 110 |
|
|
2018
Q4 | $477K | Sell |
113,485
-1,630
| -1% | -$6.85K | 0.22% | 115 |
|
|
2018
Q3 | $721K | Sell |
115,115
-10,000
| -8% | -$62.6K | 0.26% | 98 |
|
|
2018
Q2 | $1.01M | Hold |
125,115
| – | – | 0.36% | 73 |
|
|
2018
Q1 | $933K | Sell |
125,115
-10,000
| -7% | -$74.6K | 0.34% | 76 |
|
|
2017
Q4 | $804K | Sell |
135,115
-10,000
| -7% | -$59.5K | 0.29% | 82 |
|
|
2017
Q3 | $1.07M | Hold |
145,115
| – | – | 0.41% | 68 |
|
|
2017
Q2 | $985K | Buy |
145,115
+37,915
| +35% | +$257K | 0.4% | 72 |
|
|
2017
Q1 | $1.01M | Hold |
107,200
| – | – | 0.44% | 65 |
|
|
2016
Q4 | $926K | Sell |
107,200
-135,450
| -56% | -$1.17M | 0.44% | 71 |
|
|
2016
Q3 | $1.54M | Sell |
242,650
-10,000
| -4% | -$63.3K | 0.71% | 50 |
|
|
2016
Q2 | $1.07M | Sell |
252,650
-30,000
| -11% | -$127K | 0.55% | 59 |
|
|
2016
Q1 | $1.23M | Sell |
282,650
-8,500
| -3% | -$37K | 0.64% | 55 |
|
|
2015
Q4 | $1.79M | Hold |
291,150
| – | – | 0.92% | 40 |
|
|
2015
Q3 | $1.67M | Hold |
291,150
| – | – | 0.93% | 38 |
|
|
2015
Q2 | $2.17M | Hold |
291,150
| – | – | 1.04% | 36 |
|
|
2015
Q1 | $1.74M | Buy |
+291,150
| New | +$1.74M | 0.83% | 42 |
|